行情

ABMD

ABMD

阿比奥梅德
NASDAQ

实时行情|Nasdaq Last Sale

181.85
+2.70
+1.51%
盘后: 181.85 0 0.00% 16:56 12/13 EST
开盘
179.15
昨收
179.15
最高
183.13
最低
175.25
成交量
48.96万
成交额
--
52周最高
364.31
52周最低
155.02
市值
82.27亿
市盈率(TTM)
37.98
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ABMD 新闻

  • Abiomed (ABMD) Alert: Johnson Fistel Launches Investigation into Abiomed, Inc.; Investors Encouraged to Contact Firm
  • PR Newswire.1天前
  • Hedge Funds Are Selling ABIOMED, Inc. (ABMD)
  • Insider Monkey.2天前
  • These are the 20 best-performing stocks of the past decade, and some of them will surprise you
  • MarketWatch.2天前
  • Is Abiomed a Bad-News Buy Right Now?
  • MotleyFool.com.12/04 17:17

更多

所属板块

先进医疗设备和技术
+0.07%
医疗设备和用品
+0.32%

热门股票

名称
价格
涨跌幅

ABMD 简况

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.
展开

Webull提供ABIOMED, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。